Two Sigma Advisers’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,425
| Closed | -$105K | – | 2629 |
|
|
2022
Q4 | $105K | Buy |
+6,425
| New | +$105K | ﹤0.01% | 2290 |
|
|
2022
Q3 | – | Sell |
-45,700
| Closed | -$223K | – | 2597 |
|
|
2022
Q2 | $223K | Sell |
45,700
-25,300
| -36% | -$123K | ﹤0.01% | 2244 |
|
|
2022
Q1 | $534K | Buy |
71,000
+6,550
| +10% | +$49.3K | ﹤0.01% | 1958 |
|
|
2021
Q4 | $580K | Sell |
64,450
-700
| -1% | -$6.3K | ﹤0.01% | 1847 |
|
|
2021
Q3 | $1.06M | Buy |
+65,150
| New | +$1.06M | ﹤0.01% | 1590 |
|
|
2021
Q2 | – | Sell |
-4,125
| Closed | -$139K | – | 2510 |
|
|
2021
Q1 | $139K | Buy |
+4,125
| New | +$139K | ﹤0.01% | 2404 |
|